Neonatal thrombosis and its treatment

Blood Reviews

Volumn 18, Issue 2, 2004, Pages 75-84

  Greenway, A ^a   Massicotte, M P ^b   Monagle, P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

Anticoagulation; Arterial thrombosis; Neonatal thromboembolism; Potal vein thrombosis; Renal vein thrombosis; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; DANAPAROID; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ARTERY EMBOLISM; BLEEDING; BRAIN HEMORRHAGE; DRUG ANTAGONISM; ECHOGRAPHY; FIBRINOLYTIC THERAPY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INJECTION SITE; INTRAVENOUS CATHETER; KIDNEY VEIN THROMBOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; NEWBORN; NEWBORN DISEASE; OSTEOPOROSIS; OUTCOMES RESEARCH; PATIENT MONITORING; PHLEBOGRAPHY; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; REYE SYNDROME; SENSITIVITY AND SPECIFICITY; STROKE; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS; UMBILICAL ARTERY CATHETER; VENOUS THROMBOEMBOLISM;

EID: 1642280998     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(03)00042-0     Document Type: Review

References (74)

1. Andrew ME, Monagle P, deVeber G, Chan AK. Thromboembolic disease and antithrombotic therapy in newborns. Hematology (Am Soc Hematol Educ Program) 2001:358-74.
2. Andrew M, Monagle P, Brooker L. Stroke, thromboembolic complications during infancy and childhood. Hamilton, BC: Decker Inc; 2000. p. 201-30.
3. Andrew M, Monagle P, Brooker L. Congenital prothrombotic disorders: presentation during infancy and childhood, thromboembolic complications during infancy and childhood. Hamilton, BC: Decker Inc; 2000. p. 47-110.
4. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995;96:939-43.
5. Chidi CC, King DR, Bales Jr ET. An ultrastructural study of the intimal injury by an indwelling umbilical catheter. J Pediatr Surg 1983;18:109.
6. Wakefield A, Cohen Z, Rosenthal A, Craig M, Jeejeebhoy KN, Gotlieb A, Levy GA. Thrombogenicity of total parenteral nutrition solutions: II. Effect on induction of endothelial cell procoagulant activity. Gastroenterology 1989;97:1220-8.
7. Pottecher T, Forrler M, Picardat P, Krause D, Bellocq JP, Otteni JC. Thrombogenicity of central venous catheters: prospective study of polyethylene, silicone and polyurethane catheters with phlebography or post-mortem examination. Eur J Anaesthesiol 1984;1:361-5.
8. Tanke RB, van Megen R, Daniels O. Thrombus detection on central venous catheters in the neonatal intensive care unit. Angiology 1994;45:477-80.
9. Khilnani P, Goldstein B, Todres ID. Double lumen umbilical venous catheters in critically ill neonates: a randomized prospective study. Crit Care Med 1991;19:1348-51.
10. Roy M, Turner-Gomes S, Gill G. Incidence and diagnosis of neonatal thrombosis associated with umbilical venous catheters. Thromb Haemostas 1997;78:724 (abstr).
11. Schmidt B, Zipursky A. Thrombotic disease in newborn infants. Clin Perinatol 1984;11:461-88.
12. Mitchell L, Chait P, Ginsberg J, Hanna K, Andrew M. Comparison of venography with ultrasound for the detection of venous thrombosis in the upper body in children: results of the PARKAA study. Blood 1999;94(Suppl 1 (pt 1 of 2)):588a (abstr).
13. Bertrand M, Presant CA, Klein L, Scott E. Iatrogenic superior vena cava syndrome. A new entity. Cancer 1984;54:376-8.
14. Nowak-Gottl U, Von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:F163-7.
15. Le Coultre C, Oberhansli I, Mossaz A, Bugmann P, Faidutti B, Belli DC. Postoperative chylothorax in children: differences between vascular and traumatic origin. J Pediatr Surg 1991;26:519-23.
16. Kramer SS, Taylor GA, Garfinkel DJ, Simmons MA. Lethal chylothoraces due to superior vena caval thrombosis in infants. AJR Am J Roentgenol 1981;137:559-63.
17. Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium: a complication of a central venous catheter. J Pediatr 1998;132:1064-6.
18. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood 1994;83:1251-7.
19. Marzinotto V, Choi M, Massicotte MP, Chan AKC. Postthrombotic syndrome in children with previous deep vein thrombosis. Thromb Haemostas 2001;(Suppl):OC962 (abstr).
20. Barnes C, Newall F, Monagle P. Post-thrombotic syndrome. Arch Dis Child 2002;86:212-4.
21. Andrew M, Monagle P, Brooker L. Thromboembolic complications in specific organ sites and pediatric diseases, thromboembolic complications during infancy and childhood. Hamilton, BC: Decker Inc; 2000. p. 231-76.
22. Hibbert J, Howlett DC, Greenwood KL, MacDonald LM, Saunders AJ. The ultrasound appearances of neonatal renal vein thrombosis. Br J Radiol 1997;70:1191-4.
23. Cremin BJ, Davey H, Oleszczuk-Raszke K. Neonatal renal venous thrombosis: sequential ultrasonic appearances. Clin Radiol 1991;44:52-5.
24. Greene A, Cromie WJ, Goldman M. Computerized body tomography in neonatal renal vein thrombosis. Urology 1982;20:213-5.
25. Zigman A, Yazbeck S, Emil S, Nguyen L. Renal vein thrombosis: a 10-year review. J Pediatr Surg 2000;35:1540-2.
26. Kim JH, Lee YS, Kim SH, Lee SK, Lim MK, Kim HS. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001;219:645-50.
27. Kooiman AM, Kootstra G, Zwierstra RP. Portal hypertension in children due to thrombosis of the portal vein. Neth J Surg 1982;34:97-103.
28. Obladen M, Ernst D, Feist D, Wille L. Portal hypertension in children following neonatal umbilical disorders. J Perinat Med 1975;3:101-4.
29. Vos LJ, Potocky V, Broker FH, Vries JD, Postma L, Edens E. Splenic vein thrombosis with oesophageal varices: a late complication of umbilical vein catheterization. Ann Surg 1974;180:152-6.
30. Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M, Brisson L, David M, Desai S, Scully MF, Halton J, Israels S, Jardine L, Leaker M, McCusker P, Silva M, Wu J, Anderson R, Andrew M, Massicotte MP. Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry. Pediatr Res 2000;47:763-6.
31. Andrew M, Monagle P, Brooker L. Arterial thromboembolic complications in pediatric patients, thromboembolic complications during infancy and childhood. Hamilton, BC: Decker Inc; 2000. p. 165-200.
32. Cohen RS, Ramachandran P, Kim EH, Glasscock GF. Retrospective analysis of risks associated with an umbilical artery catheter system for continuous monitoring of arterial oxygen tension. J Perinatol 1995;15:195-8.
33. Hoar PF, Wilson RM, Mangano DT, Avery GJ, Szarnicki RJ, Hill JD. Heparin bonding reduces thrombogenicity of pulmonary-artery catheters. N Engl J Med 1981;305:993-5.
34. Downs JB, Chapman Jr RL, Hawkins Jr IF. Prolonged radial-artery catheterization. An evaluation of heparinized catheters and continuous irrigation. Arch Surg 1974;108:671-3.
35. The AACN Thunder Project. By the American Association of Critical-Care Nurses: Evaluation of the effects of heparinized and nonheparinized flush solutions on the patency of arterial pressure monitoring lines. Am J Crit Care 1993;2:3-15.
36. Bryant BG. Drug, fluid, and blood products administered through the umbilical artery catheter: complication experiences from one NICU. Neonatal Netw 1990;9:26-7.
37. Glickstein JS, Rutkowski M, Schacht R, Friedman D. Renal blood flow velocity in neonates with and without umbilical artery catheters. J Clin Ultrasound 1994;22:543-50.
38. Vailas GN, Brouillette RT, Scott JP, Shkolnik A, Conway J, Wiringa K. Neonatal aortic thrombosis: recent experience. J Pediatr 1986;109:101-8.
39. Sellden H, Nilsson K, Larsson LE, Ekstrom-Jodal B. Radial arterial catheters in children and neonates: a prospective study. Crit Care Med 1987;15:1106-9.
40. Rais-Bahrami K, Karna P, Dolanski EA. Effect of fluids on life span of peripheral arterial lines. Am J Perinatol 1990;7:122-4.
41. Butt W, Shann F, McDonnell G, Hudson I. Effect of heparin concentration and infusion rate on the patency of arterial catheters. Crit Care Med 1987;15:230-2.
42. Jackson JC, Truog WE, Watchko JF, Mack LA, Cyr DR, van Belle G. Efficacy of thromboresistant umbilical artery catheters in reducing aortic thrombosis and related complications. J Pediatr 1987;110:102-5.
43. Horgan MJ, Bartoletti A, Polansky S, Peters JC, Manning TJ, Lamont BM. Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications. J Pediatr 1987;111:774-8.
44. Lesko SM, Mitchell AA, Epstein MF, Louik C, Giacoia GP, Shapiro S. Heparin use as a risk factor for intraventricular hemorrhage in low-birth-weight infants. N Engl J Med 1986;314:1156-60.
45. Malloy MH, Cutter GR. The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. J Perinatol 1995;15:185-91.
46. Chang GY, Lueder FL, DiMichele DM, Radkowski MA, McWilliams LJ, Jansen RD. Heparin and the risk of intraventricular hemorrhage in premature infants. J Pediatr 1997;131:362-6.
47. Caplan MS, Cohn RA, Langman CB, Conway JA, Shkolnik A, Brouillette RT. Favorable outcome of neonatal aortic thrombosis and renovascular hypertension. J Pediatr 1989;115:291-5.
48. Seibert JJ, Northington FJ, Miers JF, Taylor BJ. Aortic thrombosis after umbilical artery catheterization in neonates: prevalence of complications on long-term follow-up. AJR Am J Roentgenol 1991;156:567-9.
49. Payne RM, Martin TC, Bower RJ, Canter CE. Management and follow-up of arterial thrombosis in the neonatal period. J Pediatr 1989;114:853-8.
50. Boros SJ, Nystrom JF, Thompson TR, Reynolds JW, Williams HJ. Leg growth following umbilical artery catheter-associated thrombus formation: a 4-year follow-up. J Pediatr 1975;87:973-6.
51. Letts M, Blastorah B, al Azzam S. Neonatal gangrene of the extremities. J Pediatr Orthop 1997;17:397-401.
52. Munoz ME, Roche C, Escriba R, Martinez-Bermejo A, Pascual-Castroviejo I. Flaccid paraplegia as complication of umbilical artery catheterization. Pediatr Neurol 1993;9:401-3.
53. Krishnamoorthy KS, Fernandex RJ, Todres ID, De Long GR. Paraplegia associated with umbilical artery catheterization in the newborn. Pediatrics 1976;58:443-5.
54. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
55. Andrew M, Paes B, Milner R, Johnston M, Mitchell L. Tollefsen DM, Castle V, Powers P. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7.
56. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992;80:1998-2005.
57. Andrew M, Marzinotto V, Massicotte P, Blanchette V, Ginsberg J, Brill-Edwards P, Burrows P, Benson L, Williams W, David M. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 1994;35:78-83.
58. Monagle P, Michelson AD, Bovitt E, Andrew M. Antithrombotic therapy in children. Chest 2001;119:344S-70S.
59. McDonald MM, Jacobson LJ, Hay Jr WW, Hathaway WE. Heparin clearance in the newborn. Pediatr Res 1981;15:1015-8.
60. Warkentin TE. Heparin-induced thrombocytopenia and its treatment. J Thromb Thrombolysis 2000;9(Suppl 1): S29-35.
61. Spadone D. Heparin induced thrombocytopenia in the newborn. J Vasc Surg 1996;15:306-12.
62. Andrew M, Ofosu F, Brooker L, Buchanan MR. The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig. Thromb Res 1989;56:529-39.
63. Albisetti M, Andrew M. Low molecular weight heparin in children. Eur J Pediatr 2002;161(2):71-7.
64. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996;128:313-8.
65. Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, deVeber G, Leaker M, Chan AK, Massicotte MP. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 2000;136:439-45.
66. Andrew M, Monagle P, Brooker L. Oral anticoagulant therapy in pediatric patients, thromboembolic complications during infancy and childhood. Hamilton, BC: Decker Inc; 2000. p. 278-356.
67. Streif W, Andrew M, Marzinotto V, Massicotte P, Chan AK, Julian JA, Mitchell L. Analysis of warfarin therapy in pediatric patients: aA prospective cohort study of 319 patients. Blood 1999;94:3007-14.
68. Massicotte P, Julian J, Webber C, Charpentier K. Osteoporosis: a potential complication of long term warfarin therapy. Thromb Haemostas 1999;(Suppl):1333a (abstr).
69. Andrew M, Brooker L, Leaker M, Paes B, Weitz J. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost 1992;68:325-30.
70. Leaker M, Massicotte MP, Brooker LA, Andrew M. Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost 1996;76:132-4.
71. Zenz W, Arlt F, Sodia S, Berghold A. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin Thromb Hemost 1997;23:321-32.
72. Farnoux C, Camard O, Pinquier D, Hurtaud-Roux MF, Sebag G, Schlegel N, Beaufils F. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr 1998;133:137-40.
73. Weitz JI, Hirsh J. New anticoagulant drugs. Chest 2001;119:95S-107S.
74. Barrington KJ. Umbilical artery catheters in the newborn: effects of catheter materials. Cochrane Database Syst Rev 2000:CD000949.